Institutional investors purchased a net $3.9 million shares of INVA during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 72.21% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CONNOR, CLARK & LUNN INVESTMENT ... Bought 709.3 Thousand shares of Innoviva Inc
VICTORY CAPITAL MANAGEMENT, INC. Bought 581.3 Thousand shares of Innoviva Inc
RENAISSANCE TECHNOLOGIES LLC Bought 458.5 Thousand shares of Innoviva Inc